Insmed Inc reports results for the quarter ended December 31 - Earnings Summary

• Insmed Inc INSM.OQ reported a quarterly adjusted loss of $1.31​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of $-1.28. The mean expectation of fourteen analysts for the quarter was for a loss of $1.16 per share. Wall Street expected results to range from $-1.39 to $-1.03 per share.

• Revenue rose 24.8% to $104.44 million from a year ago; analysts expected $102.81 million.

• Insmed Inc's reported EPS for the quarter was a loss of $1.31​.

• The company reported a quarterly loss of $235.55 million.

• Insmed Inc shares had risen by 21.4% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 0.5% in the last three months.​

• In the last 30 days, two analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 17 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Insmed Inc is $92.00

This summary was machine generated from LSEG data February 20 at 08:10 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)